Research Article
Role of Helicobacter pylori Eradication Therapy on Platelet Recovery in Chronic Immune Thrombocytopenic Purpura
Table 1
Baseline demographic and clinical characteristics of study patients (
).
| Parameter | HpSA positive | HpSA negative | |
| Age (years) | 43.89 ± 7.06 | 44.75 ± 7.91 | 0.53 | Male | 12 | 20 | —
| Female | 22 | 31 | — | Hemoglobin (g/dl) | 11.54 ± 1.68 | 12.19 ± 2.06 | 0.12 | Hematocrit (%) | 45.0 ± 7.5 | 47.0 ± 8.0 | 0.30 | RBC (million/µl) | 2.91 ± 0.49 | 3.34 ± 0.55 | 0.0001 | WBC (per µl) | 6283.7 0.310 | 6239.0 ± 0.311 | 0.01 | Platelets ( 103/µl) | 12.3 3.7 | 13.5 4.1 | 0.9 |
|
|
HpSA: Helicobacter pylori stool antigen; : total number of patients. Based on Student’s -test.
|